Direct to consumer advertising

Include cost of treatment

BMJ 2008; 336 doi: 10.1136/bmj.39542.430451.3A (Published 10 April 2008)
Cite this as: BMJ 2008;336:788.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Anthony N Glaser, assistant professor of family medicine
  1. 1Medical University of South Carolina, Charleston, SC 29483, USA
  1. tonyglaser{at}mindspring.com

    Practising in the United States, I am well acquainted with direct to consumer advertising of prescription drugs.1 I suggest (and have suggested in the past to the Food and Drug Administration) that if such advertising …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL